Zhongmou Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Zhongmou Therapeutics General Information

Description

Manufacturer of gene therapy and optogenetics designed to advance broad-spectrum and mutation-independent treatments for retinal degenerative diseases. The company offers AAV vector engineering capabilities and a comprehensive optogenetic visual restoration platform, enabling patients with hereditary and acquired retinal disorders to regain functional sight through durable and widely applicable gene therapy.

Contact Information

Website
zmtherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4th Floor, Unit 2, Building C4, Optics Valley Bio-city
  • East Lake High-tech Development Zone
  • Wuhan, Hubei 430205
  • China
+86 130
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Manufacturing
Corporate Office
  • 4th Floor, Unit 2, Building C4, Optics Valley Bio-city
  • East Lake High-tech Development Zone
  • Wuhan, Hubei 430205
  • China
+86 130

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zhongmou Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 03-Dec-2025 Completed Generating Revenue
1. Later Stage VC 28-Jul-2025 Completed Generating Revenue
To view Zhongmou Therapeutics’s complete valuation and funding history, request access »

Zhongmou Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Huatai Zijin Investment Corporate Venture Capital Minority
Jifeng Ventures Venture Capital Minority
Shenzhen Yifeng Investment Management Enterprise Venture Capital Minority
Wuhan Institute of Biotechnology Government Minority
To view Zhongmou Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Zhongmou Therapeutics FAQs

  • When was Zhongmou Therapeutics founded?

    Zhongmou Therapeutics was founded in 2019.

  • Where is Zhongmou Therapeutics headquartered?

    Zhongmou Therapeutics is headquartered in Wuhan, China.

  • What industry is Zhongmou Therapeutics in?

    Zhongmou Therapeutics’s primary industry is Biotechnology.

  • Is Zhongmou Therapeutics a private or public company?

    Zhongmou Therapeutics is a Private company.

  • What is Zhongmou Therapeutics’s current revenue?

    The current revenue for Zhongmou Therapeutics is .

  • Who are Zhongmou Therapeutics’s investors?

    Huatai Zijin Investment, Jifeng Ventures, Shenzhen Yifeng Investment Management Enterprise, and Wuhan Institute of Biotechnology have invested in Zhongmou Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process